Redefining Cancer Care with Precision and Expertise
Pioneering the future of cancer research with groundbreaking CAR-T and NK cell therapies.
Advancing innovation with our GMP lab in Malaysia opening in 2025.
Revolutionizing Cancer Care
Transforming cancer care with relentless innovation. We are reimagining what’s possible in cancer treatment, driving progress in CAR-T cell therapy, NK cell research, and advanced diagnostic tools.
Founded in 2020, we are not just solving today’s challenges—we are shaping the future of cancer care. With cutting-edge therapies and a GMP lab in Malaysia set to open in 2025, we aim to bring life-changing breakthroughs to patients around the globe.
Research Focus
CAR-T Cell Therapy
Pioneering CAR-T cell treatments for leukemia and other blood cancers.
NK Cell Research
Harnessing the power of Natural Killer cells to combat solid tumors.
Cancer Test Kits
Developing rapid and accurate diagnostic tools for early cancer detection.
Exosomes
Advancing regenerative medicine with exosomes for tissue repair and healing.
A World Beyond Cancer
We see a future where cancer is met with precision, resilience, and hope. Through CAR-T and NK cell therapies, we are reimagining treatments that leverage the body's own defenses to outsmart disease.
Driven by cutting-edge biotech and a deep understanding of cancer biology, our work is focused on improving patient outcomes and creating therapies that change lives. This is our commitment to shaping a healthier tomorrow.
Revolutionizing Cancer Care Through Science
CAR-T Cells
NK Cells
Test Kits
At Alpha Biomedical, we're dedicated to pioneering cancer research and developing cutting-edge treatments. Our patient-centered approach drives us to push the boundaries of science, always with the goal of improving lives.
"Committed to curing cancer one breakthrough at a time."
Our Research
Cancer Treatment & CAR-T Cell Therapy
R&D in Cancer Test Kits
NK Cells Research
MSC Stem Cell & Exosome Trials
Cancer Treatment & CAR-T Cell Therapy
Developing innovative CAR-T cell therapies for leukemia and lymphoma, accelerated by our recent technology transfer agreement.
Milestones & Achievements
Latest Announcements
Stay updated with our milestones, breakthroughs, and ongoing progress.
ResearchPartnering with US Biotech for CAR-T Technology Transfer
Alpha Biomedical is partnering with a US biotech company for the transfer of CAR-T technology, enabling us to quickly bring innovative cancer therapies to market.
MilestoneExpansion to Japan with New Tokyo Subsidiary
A strategic expansion strengthens our presence in the Asia-Pacific region, bringing our cutting-edge solutions closer to partners and clients.
EventsArab Health 2024: Alpha Biomedical’s Innovative Exhibit
Alpha Biomedical showcased transformative therapies at Arab Health 2024, reaffirming our commitment to advancing cancer care and biomedical innovation.